Smith; Cameron J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Smith; Cameron J..The latest application filed is for "soluble guanylate cyclase stimulators".
- Smith; Cameron J. - Montgomery Village MD
- Smith; Cameron J. - Lawrenceville NJ
| Patent | Date |
|---|---|
| Soluble guanylate cyclase stimulators Grant 10,428,076 - Berger , et al. October 1, 2 | 2019-10-01 |
| Soluble Guanylate Cyclase Stimulators App 20180305366 - Berger; Raphaelle ; et al. | 2018-10-25 |
| Soluble guanylate cyclase stimulators Grant 10,030,027 - Berger , et al. July 24, 2 | 2018-07-24 |
| Spirocyclic CETP inhibitors Grant 9,717,714 - Ondeyka , et al. August 1, 2 | 2017-08-01 |
| Soluble Guanylate Cyclase Stimulators App 20170174693 - Berger; Raphaelle ; et al. | 2017-06-22 |
| Soluble guanylate cyclase activators Grant 9,365,574 - Raghavan , et al. June 14, 2 | 2016-06-14 |
| CETP Inhibitors App 20160075724 - Ali; Amjad ; et al. | 2016-03-17 |
| Spirocyclic Cetp Inhibitors App 20150342931 - Ondeyka; Debra ; et al. | 2015-12-03 |
| Cetp Inhibitors App 20140221383 - Ali; Amjad ; et al. | 2014-08-07 |
| CETP inhibitors Grant 8,735,435 - Ali , et al. May 27, 2 | 2014-05-27 |
| 1,3-oxazolidin -2-one derivatives useful as CETP inhibitors Grant 8,440,702 - Ali , et al. May 14, 2 | 2013-05-14 |
| Soluble Guanylate Cyclase Activators App 20130072492 - Raghavan; Subharekha ; et al. | 2013-03-21 |
| CETP inhibitors Grant 8,334,290 - Ali , et al. December 18, 2 | 2012-12-18 |
| 1,3-oxazolidin -2-one Derivatives Useful As Cetp Inhibitors App 20110178059 - ALI; Amjad ; et al. | 2011-07-21 |
| 1,3-oxazolidin-2-one derivatives useful as CETP inhibitors Grant 7,915,271 - Ali , et al. March 29, 2 | 2011-03-29 |
| CETP inhibitors Grant 7,910,592 - Ali , et al. March 22, 2 | 2011-03-22 |
| CETP inhibitors Grant 7,781,426 - Ali , et al. August 24, 2 | 2010-08-24 |
| Cetp Inhibitors App 20100099716 - ALI; Amjad ; et al. | 2010-04-22 |
| Selective spirocyclic glucocorticoid receptor modulators Grant 7,662,846 - Ali , et al. February 16, 2 | 2010-02-16 |
| CETP inhibitors Grant 7,652,049 - Ali , et al. January 26, 2 | 2010-01-26 |
| Cetp Inhibitors App 20090264405 - Ali; Amjad ; et al. | 2009-10-22 |
| 1,3-Oxazolidin-2-One Derivatives Useful as Cetp Inhibitors App 20090137548 - Ali; Amjad ; et al. | 2009-05-28 |
| CETP Inhibitors App 20090075979 - Ali; Amjad ; et al. | 2009-03-19 |
| Cetp Inhibitors App 20090042892 - Ali; Amjad ; et al. | 2009-02-12 |
| Cetp Inhibitors App 20080119476 - Ali; Amjad ; et al. | 2008-05-22 |
| Selective spirocyclic glucocorticoid receptor modulators App 20060217563 - Ali; Amjad ; et al. | 2006-09-28 |
| CETP inhibitors App 20060040999 - Ali; Amjad ; et al. | 2006-02-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 